Skip to main content
Clinical Trials/NCT02347696
NCT02347696
Unknown
N/A

Effect of Two Programs of Physical Activity of Different Intensity, Mediterranean Diet and the Combination of Both on NAFLD and Erytrocyte Membrane Lipid Profile.

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis1 site in 1 country240 target enrollmentMarch 2015
ConditionsNAFLD

Overview

Phase
N/A
Intervention
Not specified
Conditions
NAFLD
Sponsor
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Enrollment
240
Locations
1
Primary Endpoint
Non-Alcoholic Fatty liver Disease (NAFLD) score
Last Updated
9 years ago

Overview

Brief Summary

This study aims to evaluate the effect of two programs of different intensity level of physical activity, of low glycemic index Mediterranean Diet and of the interaction of both, on NAFLD score and on the lipid composition of the erythrocyte membrane.

Detailed Description

The surveys conducted on the populations of Castellana Grotte and Putignano (Bari, Italy) evidenced that Non-Alcoholic Fatty liver Disease (NAFLD) reaches a prevalence of 30%, especially among aged and male individuals. Being a crucial outcome of several metabolic alterations, it becomes imperative for Public Health to adopt strategies aimed to control the factors responsible for NAFLD onset. The objective of this study is to evaluate the effect of two programs of different intensity level of physical activity, of low glycemic index Mediterranean Diet and of the interaction of both, on NAFLD score and on the lipid composition of the erythrocyte membrane. Study participants responding to the inclusion criteria of this trial will be chosen both in the hospital setting and in the general practitioners' clinics. At the enrollement, anthropometric and biochemical variables will be measured, as well as bioimpedenziometric and calorimetric parameters; participants will also undergo Fibroscan-CAP to measure the outcome and will be asked about their medical history and life-style. Subjects will be randomized to the different arms of the trial and be followed-up at the end of the sixth and the twelfth week of enrollement. All data will be statistically analysed by applying the Chi-Square test and t-test for discrete and continuous variables, respectively. As it deals with the analysis of data repeatedly measured on the same subject, the Generalized Estimating Equation (GEE) will be applied to evaluate the effect of the intervention on the outcomes.

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
December 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Responsible Party
Principal Investigator
Principal Investigator

Alberto R Osella

MD, PhD

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Eligibility Criteria

Inclusion Criteria

  • BMI ≥ 25.0
  • Moderate or severe NAFLD
  • 30 \< age \<60

Exclusion Criteria

  • Overt cardiovascular disease and revascularization procedures;
  • Clinical peripheral artery disease;
  • Type-2 Diabetes Mellitus (current treatment with insulin or oral hypoglycemic drugs, fasting glucose \>126 mg/dl, or casual glucose \>200 mg/dl);
  • Severe medical condition that may impair the person to participate in a nutritional intervention study;
  • Impossibility to follow Mediterranean Diet for religious or other reasons.

Outcomes

Primary Outcomes

Non-Alcoholic Fatty liver Disease (NAFLD) score

Time Frame: up to 12 weeks

NAFLD score will be built with Fobroscan-CAP

Secondary Outcomes

  • Sierical lipid profile(6 and 12 weeks)
  • Lipid composition of erythrocyte membrane(6 and 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials